Barron’s 400 ETF (NYSEARCA:BFOR) Shares Down 4.4% – What’s Next?
by Sarita Garza · The Markets DailyBarron’s 400 ETF (NYSEARCA:BFOR – Get Free Report)’s stock price traded down 4.4% during trading on Thursday. The stock traded as low as $22.60 and last traded at $22.60. 6,408 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 31,133 shares. The stock had previously closed at $23.65.
Barron’s 400 ETF Stock Down 4.4%
The stock has a market cap of $232.78 million, a PE ratio of 16.61 and a beta of 1.02. The stock has a 50-day moving average of $23.46 and a 200 day moving average of $22.72.
Institutional Trading of Barron’s 400 ETF
Hedge funds and other institutional investors have recently modified their holdings of the stock. Integrated Wealth Concepts LLC acquired a new stake in shares of Barron’s 400 ETF in the 2nd quarter worth $142,000. Bank of America Corp DE boosted its position in shares of Barron’s 400 ETF by 7.2% during the 1st quarter. Bank of America Corp DE now owns 58,313 shares of the company’s stock valued at $4,840,000 after acquiring an additional 3,935 shares during the last quarter. Asset Dedication LLC acquired a new position in shares of Barron’s 400 ETF during the 3rd quarter valued at about $148,000. Aspire Capital Advisors LLC purchased a new stake in shares of Barron’s 400 ETF in the second quarter valued at about $636,000. Finally, Trilogy Capital Inc. grew its holdings in shares of Barron’s 400 ETF by 21.9% in the second quarter. Trilogy Capital Inc. now owns 43,999 shares of the company’s stock valued at $4,207,000 after purchasing an additional 7,908 shares during the period.
About Barron’s 400 ETF
The Barron’s 400 ETF (BFOR) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an equally weighted index comprising 400 US companies selected on fundamental parameters. BFOR was launched on Jun 4, 2013 and is managed by ALPS.
Further Reading
- Five stocks we like better than Barron’s 400 ETF
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market